It can be inferred that factors associated with obesity may significantly influence the regulation of these variables, and the LC protocol (with longer recovery times) may have a greater capacity to reduce inflammatory biomarkers, particularly NLRP3. The gene discussed is NLRP3; the disease is Obesity.